In exercise of the powers conferred by section 3 of the Essential Commodities Act,

Okay, I'm ready to analyze the provided policy text and generate the report. **Report on Drugs Prices Control Amendment Order, 2021** **1. Executive Summary:** This report analyzes the Drugs Prices Control Amendment Order, 2021. This amendment to the Drugs Prices Control Order, 2013, adds medicines for animal use, specifically Foot and Mouth Disease Trivalent Oil adjuvant vaccine and Brucella Abortus S19 strain Vaccine, Live Freeze Dried, to Schedule I, thereby placing them under price control. The key finding is that this amendment directly affects the pricing and availability of these veterinary vaccines. **2. Introduction:** The purpose of this report is to provide a detailed analysis of the Drugs Prices Control Amendment Order, 2021, based solely on the information provided in the official gazette notification. The report outlines the amendment's key provisions, its potential impact, and the stakeholders affected. **3. Policy Overview:** * This document is an amendment to the Drugs Prices Control Order, 2013. * **Core Objective:** Based on the text, the core objective is to extend price control measures to specific medicines used in animal healthcare, focusing on Foot and Mouth Disease and Brucellosis vaccines. This suggests an aim to ensure affordability and accessibility of these essential veterinary medicines. **4. Background and Rationale:** This is an amendment, therefore we explain the likely reason *for this specific amendment*. By including these veterinary vaccines under the Drug Prices Control Order, the government likely intends to address issues of pricing and availability. The original policy may not have adequately covered essential animal health products, and this amendment is designed to rectify that omission. The inclusion suggests a perceived need to regulate the prices of these vaccines to ensure their accessibility to farmers and animal healthcare providers. **5. Key Provisions / Changes:** This is an amendment. Therefore, we focus *specifically* on the changes introduced. * **What specific part of the original policy is being changed:** Schedule I of the Drugs Prices Control Order, 2013. * **What the *new* rule/provision *is*:** Two new entries, numbered 32, are added to Schedule I: * 32.1 Foot and Mouth Disease Trivalent Oil adjuvant vaccine * 32.2 Brucella Abortus S19 strain Vaccine, Live Freeze Dried * **Explain the *difference* or the *effect* of this specific change:** Prior to this amendment, these specific veterinary vaccines were *not* subject to the price control mechanisms outlined in the Drugs Prices Control Order, 2013. The effect of this change is to now bring these vaccines under the purview of the price control order, meaning their prices will be regulated according to the rules and guidelines set forth in the original order. This likely involves price ceilings, monitoring of pricing practices, and potential penalties for non-compliance. **6. Target Audience and Stakeholders:** Based on the provided text, the primary target audience and stakeholders are: * Manufacturers and suppliers of Foot and Mouth Disease Trivalent Oil adjuvant vaccine and Brucella Abortus S19 strain Vaccine, Live Freeze Dried. * Veterinarians and animal healthcare providers who prescribe or administer these vaccines. * Livestock farmers and other individuals or organizations that rely on these vaccines for animal health management. * The National Pharmaceutical Pricing Authority (NPPA), responsible for implementing and enforcing the Drugs Prices Control Order. **7. Implementation Aspects (Inferred):** * **Responsible agency/bodies:** The text explicitly mentions the Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals as the issuing authority. The NPPA is implicitly responsible for implementation, as they oversee the Drugs Prices Control Order. * **Timelines or procedures:** The amendment came into force on the date of its publication in the Official Gazette, which was February 1st, 2021. The text does not specify further timelines or procedures, but these would likely be governed by the existing procedures outlined in the Drugs Prices Control Order, 2013, regarding price fixation, monitoring, and enforcement. * **Specifically to the changes:** Manufacturers of the listed vaccines will now need to comply with the price control regulations. This likely includes submitting pricing data to the NPPA and adhering to any price ceilings that are set. **8. Expected Outcomes / Impact of Changes:** The likely intended outcome of these specific changes is: * **Price Regulation:** The primary impact is on the pricing of Foot and Mouth Disease and Brucellosis vaccines. The prices of these vaccines will be subject to regulation, potentially leading to lower prices for end-users (farmers, etc.). * **Increased Accessibility:** By controlling prices, the government aims to increase the accessibility of these vaccines, particularly for smaller farmers who may have previously been unable to afford them. * **Market Impact:** Vaccine manufacturers may experience reduced profit margins on these specific products, which could potentially impact their investment in research and development or their overall production strategies. * **Enhanced Animal Health:** Increased accessibility to these essential vaccines should contribute to improved animal health and disease control, benefiting the livestock industry as a whole. **9. Conclusion:** The Drugs Prices Control Amendment Order, 2021, represents a targeted effort to extend price control measures to specific vaccines essential for animal health, namely Foot and Mouth Disease and Brucellosis vaccines. This amendment signifies the government's intention to ensure the affordability and accessibility of these critical veterinary medicines, potentially benefiting farmers, animal healthcare providers, and the livestock industry. This amendment is a small but potentially significant step toward better animal health management through price regulation.

Key Entities Referenced